FOXM1 drives cisplatin resistance in ovarian cancer through STIM1-mediated SOCE and STAT1 activation
Cisplatin resistance remains a major challenge in ovarian cancer, limiting treatment efficacy and reducing patient survival. While FOXM1 and calcium (Ca2+ signaling have been individually implicated in chemoresistance, how transcriptional regulation is linked to Ca2+-dependent survival signaling remains poorly understo...